For delegates
Late phase drug development is growing at around 20% annually, exceeding the growth rate of Phase II and III Trials. In excess of $12 billion is currently being spent on Phase IIIb/IV studies as public concerns on the safety of approved drugs prevail together with the need to evaluate real world safety and effectiveness of marketed drugs. More than ever before there is the urgent need to detect, quantify and communicate patient risk with speed and efficiency.

As a result, Health Network Communications is delighted to announce the first ever strategic forum in the US addressing the major challenges in conducting strategic and compliant late stage studies.

Network with your late phase peers

» Request brochure
» Register now

Our speakers
Our eminent speaker panel will include thought leaders and practitioners in late phase trials from the industry, academia and contract services. You can expect to see speakers from a wide range of countries. There will be case study updates, and we will introduce fresh strategy content as we continue to keep track of the latest developments.

» Get my quote

For sponsors
Position and profile yourself as an industry leader at the most prestigious meeting place of the year. As a sponsor of this event you will be able to consider the most appropriate way to present your products and services and select a sponsorship package that is best suited to your marketing objectives.   

» Find out how you could benefit